MEB 1997
Alternative Names: MEB-1997Latest Information Update: 31 May 2023
At a glance
- Originator MEBIAS Discovery
- Class Analgesics; Anti-inflammatories
- Mechanism of Action Sphingosine 1 phosphate receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Neuropathic pain
Most Recent Events
- 02 Feb 2023 Preclinical trials in Neuropathic pain in USA (unspecified route) (MEBIAS Discovery pipeline, February 2023)